A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes.
Ontology highlight
ABSTRACT: Diabetes mellitus is a multifactorial global health disorder that is rising at an alarming rate. Cardiovascular diseases, kidney damage and neuropathy are the main cause of high mortality rates among individuals with diabetes. One effective therapeutic approach for controlling hyperglycemia associated with type-2 diabetes is to target alpha-amylase and alpha-glucosidase, enzymes that catalyzes starch hydrolysis in the intestine. At present, approved inhibitors for these enzymes are restricted to acarbose, miglitol and voglibose. Although these inhibitors retard glucose absorption, undesirable gastrointestinal side effects impede their application. Therefore, research efforts continue to seek novel inhibitors with improved efficacy and minimal side effects. Natural products of plant origin
SUBMITTER: Dirir AM
PROVIDER: S-EPMC8364835 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA